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Kota Bharua, Kelantan, MalaysiaReceived 26 September 2005; accepted 28 September 2005Summary Malignant fibrous histiocytoma (MFH) of the maxilla is a rare neoplasm. A round 61
cases reported in the international literature since 1974. We present a rare case of primary MFH
of the maxilla in the unusual location of maxilla in a 64-year-old man. The tumor was located in
the left tuberosity of maxilla extending from the junction between soft and hard palate towards
premolar area of edentulous ridge, and measured 7 cm · 6 cm. Histologically, it consisted of
spindle-shaped, pleomorphic malignant cells in a storiform pattern associated with histio-
cyte-like cells and giant cells. Mitotic figures were frequent Immunohistochemically, most of
the tumor cells were strongly positive for vimentin, and negative with S-100 protein, cytoker-
atin, actin, desmin, HMB45 and epithelial membrane antigen. Ultra structurally, the tumor have
clearly shown spindle shaped fibroblastic and giant cells with well-known pleomorphic multi-
segmented nuclei, prominent branching and often dilated rough endoplasmic reticulum
(RER). Histopathological and ultra structural findings are consistent with high-grade MFH of
the storiform/pleomorphic subtype. Four months later the patient came with residual/recur-
rent tumor that was confirmed histopathologically. The literature is briefly reviewed.c 2005 Elsevier Ltd. All rights reserved.
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Arthur purdy stout, coined the term malignant fibrous histi-
ocytoma, on the basis of tissue culture studies made by Mar-
garet Murray, which purportedly showed that these
pleomorphic fibroblastic tumors arose from tissue histio-
cytes capable of fibroblastic transformation ‘‘facultative
fibroblasts’’. Enzinger and Weiss subsequently defined five
subtypes of MFH as follows: (1) storiform-pleomorphic, (2)
myxoid, (3) giant cell, (4) inflammatory, and (5) angioma-
toid. MFH is the most common adult soft tissue sarcoma.1
Recently there are controversial entities regarding tumors
of fibroblastic differentiation. The ubiquitous fibroblast is
capable of a wide variety of morphologic and functional
adaptation in relation to its body site as well as local phys-
iologic and pathologic changes. The active collagen synthe-
sizing fibroblast is a spindle shaped or plump epithelioid cell
with prominent juxtanuclear Golgi apparatus and well
developed branching rough endoplasmic reticulum (RER).2
There is longstanding disagreement as to whether the cell
type composing MFH is a histiocyte or a fibroblast. Initially,
it was proposed by Ozzello et al.3 that the cell was ‘‘facul-
tative fibroblasts’’ (a histiocyte that could appear and func-
tion as a fibroblast). However, the majority of more recent
histochemical, immunohistochemical, and ultrastructural
studies of this tumor support the contention that MFH is a
form of fibrosarcoma.1,2,4,5 Previously the diagnosis is made
on the basis of the histological appearance. Recently, dis-
tinction among these pleomorphic soft tissue tumors is best
achieved by a joint immunohistochemical and ultra struc-
tural study.2
Malignant fibrous histiocytoma, the most common soft
tissue sarcoma of adults has a variety of morphological
appearance ranging from a markedly myxoid tumor to a
hypercellular, often pleomorphic neoplasms. Frequently
present are cell in a storiform arrangement.
Malignant fibrous histiocytomas can arise from soft tissue
or bone. It’s most common in the soft tissues of the abdo-
men and extremities, with 23% occur in osseous sites.
Although it can be found in the head and neck region, its
occurrence is uncommon, accounting for 3–8.5% of the
cases6,7 Peak occurrence is in persons aged 50–70 years. A
slight male predominance is observed. It can occur every-
where, owing to its mesenchymal origin.8,9 The most com-
mon sites of occurrence in the head and neck are the
sinonasal tract.10 soft tissues of the neck, craniofacial
bones, and salivary glands. A literature search showed
around 61 well-documented cases of malignant fibrous histi-
ocytoma arising at maxilla, maxillary sinuses and zygoma
(Table 1).11–40
We describe interesting case of unusual location at left
tuberosity of maxilla tumors that had been diagnosed at a
very late stage.
Report of the case
A 64-year-old Malay man presented with swelling at left
tuberosity of maxilla, which was noticed 2 months prior to
seeking treatment. Lately, however the swelling was found
to be painful and easily bleed during eating. Upon examina-
tion, there was a huge exophytic growth measuring7 cm · 6 cm over the left tuberosity of maxilla extending
from the junction between soft and hard palate towards
premolar area of edentulous ridge (Fig. 1). The growth
extended laterally from the vestibule to the midline. Clini-
cally, regional lymph nodes were not palpable. Radiographic
examination showed aggressive enhances soft tissue mass at
left infratemporal space posterior to left pterygoid plate of
maxilla. Diffuse within the lateral pterygoid muscle. The
mass occupied the left part of hard palate extending to
premolar area in which involving the midline. A computed
tomography scan (Plain and CECT) from base of skull to
thoracic inlet revealed an ill defined soft tissue mass
with heterogenous enhancement noted in the left palatine
region with central non-enhancement suggestive of central
necrosis. It measures 3.6 cm (AP) · 4.1 cm (W) · 5.0 cm
(CC). Superiorly the mass extends till the nasopharynx (at
C1 level) with obliteration of the right fossa of Rosen Muller.
Inferiorly it extends to the level of tongue. Both parotid
and submandibular glands are not involved (Fig. 2A and B).
The patient underwent to left lower level partial hemimax-
illectomy. A soft grayish to pinkish homogeneous tumor
mass measuring 8 · 7 · 3 cm was removed and submitted
for oral pathology laboratory. Unfortunately this patient
had been defaulted the radiotherapy treatment, which
was planned earlier as adjunct to the surgery (Fig. 3). He
came back to clinic four months later with residual/recur-
rent tumor, which was confirmed histopathologically.
Materials and methods
Tumor mass was cut into small portions, some of these por-
tions were fixed in 10% neutral buffered formalin, processed
for light microcopy and stained with hematoxylin and eosin.
For imunohistochemical staining 4 mm thick sections from
selected paraffin block were stained with vimentin, S-100
protein, cytokeratin, actin, desmin, HMB45 and epithelial
membrane antigen. For transmission electron microscopy
study, a portion of solid mass was cut into 1 mm fragments,
fixed in 2.5% gluteraldehyde and post-fixed in spur resin.
After examination of 1 lm survey semi-ultrathin sections,
ultrathin sections were cut and stained with uranyl acetate
followed by lead citrate. The specimen was examined by
transmission electron microscope (TEM) (Zeiss, Germany).
Results
Microscopically, the mass contained interlacing pleomor-
phic mix of fibroblasts and multi-nucleated cells revealed
bizarre nuclei, abundant eosinophilic cytoplasm, and abnor-
mal frequent mitotic figures. Fibroblastic spindle cells ar-
ranged in fascicles and myxoid pattern. Necrosis and
extensive cellular atypia were also seen. Many areas re-
vealed spindle cells arranged in a storiform pattern. Histio-
cyte-like cells interspersed between the spindle cells
(Fig. 4A and B).
Immunohistochemically, most of the tumor cells (80%)
were strongly positive for vimentin (Fig. 5A and B) and neg-
ative with S-100 protein, cytokeratin, actin, desmin, HMB45
and epithelial membrane antigen.
Ultrastructural evaluation of the MFH revealed stori-
form–pleomorphic subtype. The section consisted of spin-
Table 1 Reported cases of maxilla malignant fibrous histiocytomas (Pr—primary, Met—metastasis, Rec—recurrences, S—surgery, R—radiation, C—chemotherapy, L—regional lymph
nod, DC—died of disease, AO—alive without disease, AC—alive with disease, NM—non-mentioned)
No. Author & year Case Sex Age (Year) Site of lesion Treat Rec Met Follow up Status
1. Watanabe (2005) 1 case Pr/MFH M 83 Right maxilla C+ Bounding NM NM 13 months DC
2. Sabesan et al.
(2005)
15 cases Pr/MFH NS Mean age
43 (13–83)
Maxilla S NM NM NM NM
3. Chan et al. (2004) 1 case Pr/MFH F 44 Left maxillary
molar region
S + R   17 months AO
4. Yamaguchi et al. (2003) 1. Pr/MFH M 29 Max sinus S + C +  1 year DC
2. Pr/MFH M 56 Maxilla S + C + R   11 years,
8 months
AO
3. Pr/MFH M 57 Max sinus S + L 9 months DC
4. Pr/MFH M 63 Max sinus S + C + R   5 years AO
5. Sato et al. (2001) 1. Pr/MFH F 48 Left maxillary
molar region
S + +/Lung
Met
Several
months
DC
2. Pr/MFH F 47 Right maxillary
premolar regions
S + C + +/Skin
bone
lung
2 years DC
5. Mardinger et al. (2001) 1 case Pr/MFH/high grade F 32 Post-maxillary and
alveolar ridge
S NM NM NM NM
6. Pandy et al. (2000) 1 case Pr/MFH M 54 Zygoma + Maxilla S(WE) + R R after
18
months
NM 77 months AO
7. Amante (1997) 1 case Pr/MFH F 40 Maxilla S + C NM NM 8 months DC
8. Li et al. (1997) 1 case/after radiation M 47 Maxillary sinus S + R + NM 10 months AC/Deteriorate
condition
9. Lin et al. (1994) 2 cases/after radiation NM NM Maxilla NM NM NM 17
months
AC/Very poor
after 17 month
survive
10. Besly et al. (1993) 2 case s/Pr/MFH NM NM Maxilla S NM NM NM NM
11. Wang (1993) 1 case/Pr/MFH F 19 Maxilla S NM NM NM NM
12. Paume et al. (1993) 1 case/an anaplastic sarcomatous
zone of the malignant fibrous
histiocytoma (MFH) type
F 19 Maxilla S R L NM NM
13 Namyslowski et al. (1993) 1 case/Pr/MFH F 71 Maxilla S NM NM NM NM
14. Takahashi and Sato (1991) 1 case/Pr/MFH F 45 Maxilla S NM NM NM NM
15. Ireland et al. (1988) 2 cases/MFH after radiation NM NM Maxilla S NM NM NM NM
16. Min (1988) 1 case/Pr/MFH (article in
Korean language)
17. Fan et al. (1986) 7 cases/Pr/MFH NM NM Maxilla S NM NM NM NM
Tagawa et al. (1986) 1 case/Pr/MFH NM NM Right maxilla NM NM NM NM NM
18. Block et al. (1986) 1 case/Pr/MFH NM NM Maxillary sinus S NM NM NM NM
19. Karcher et al. (1986) 1 case/Pr/MFH NM NM Maxilla S NM NM NM NM
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Figure 1 Photograph shows the clinical appearance of a huge
exophytic growth measuring 7 cm · 6 cm over the left tuberos-
ity of maxilla extending from the junction between soft and
hard palate towards premolar area of edentulous ridge.
118 K.A. Al-Salihi et al.dle shaped and giant fibroblastic cells with markedly pleo-
morphic multi-segmented nuclei, well developed branching
rough endoplasmic reticulum contained a finely granular
substance and more electron dense material. Primarily
peripheral bundles of actin microfilaments with inter-
spersed fusiform densities were also seen. Subplasmalem-
mal attachment plaques, focal basal lamina-like material,
and micropinocytotic vesicles were present to variable de-
grees in these cells. Fibroblasts transformed into a contrac-
tile myfibroblast were well identified by exposed peripheral
arrays of actin microfilaments. The intermediate filaments
were found in a plenty amount and observed in the cyto-
plasm of spindle fibroblast-like cells joined by rudimentary
cell junction (Fig. 6A–D).
Discussion
‘‘As reflected in the World Health Organization classifica-
tion of soft tissue tumors, so called malignant fibrous histi-
ocytoma can no longer be regarded as a definable entity,
and is now viewed as a synonym for undifferentiated pleo-
morphic sarcoma.41 Malignant Fibrous histiocytoma is the
most common soft tissue sarcoma, first described by Ozzelo
et al. and O’Brien and Stout3,8 The storiform-pleomorphic
type is the most common and is a highly cellular tumor,
which can range from well differentiated to anaplastic.
MFH affects individuals later in life and occurs more often
in men, with an approximate 2:1 male:female ratio.
Maxillary MFH is very rare. It was first reported in 1974.40
The review of the literature produced 61 well-documented
cases of maxillary malignant fibrous histiocytoma (Table
1)11–39 ranging in age from 12 to 83 years, with a median
age of 44.7 years. Most patients 54/61 (88.5%) showed clin-
ical signs of primary maxillary MFH. MFH can also arise in the
site of previous radiation. However, radiation induced MFH
of the head and neck is exceedingly rare. A literature search
showed only 7/61 cases (11.47%) of post-radiation maxilla
MFH.19,20,26,33,35 The sinonasal tract has been reported to
be the commonest site (30%) of tumor involvement in the
Figure 2 (A) and (B): computed tomography revealed an ill defined soft tissue mass with heterogeneous enhancement noted in the
left palatine region with central non-enhancement suggestive of central necrosis.
Figure 3 Photograph shows surgical location 10 days post-
operation.
Figure 4 Photomicrographs reveal histological features of
malignant fibrous histiocytoma: (A) low power magnification of
histopathology showing a markedly cellular spindle-cell neo-
plasm with a diffuse growth pattern reveals multiple dissem-
inated nodular cellular masses (·100) and (B) high-power
magnification showing nuclear pleomorphism and mitotic activ-
ity. Note the histiocyte (arrow) with an indented nucleus and
abundant cytoplasm (·200).
Maxilla tuberosity malignant fibrous histiocytoma with giant fibroblastic cells 119head and neck region.10 But Sabesan et al.12 found that
maxilla is the most common site (15/54 cases). This
literature review of Maxilla MFH revealed that 41/61 cases
(67.2%) of the lesions were located in maxilla11–15,17,18,20–
30,32–40 while, only 5/61 cases (8.19%) in maxillary
sinus,14,19,30 and only two cases (3.2%) reported in post-
maxillary and alveolar ridge16 and in zygoma17 respectively.
Our patient showed painful, easily bleed swelling at left
tuberosity of maxilla. The lesion appeared as primary huge
exophytic growth measuring 7 cm · 6 cm over the left
tuberosity of maxilla extending from the junction between
soft and hard palate towards premolar area of edentulous
ridge. The growth extended laterally from the vestibule to
the midline. This case presented uncommon location has
not reported previously in literature.
Few reports have dealt with the radiographic findings of
MFH.42–44 Reported radiographic findings were irregular
bone margin, a moth-eaten appearance, erosion of cortex,
pathological fracture, and tooth root resorption. Although,
these radiographical findings are not specific to MFH, and
are usually also observed in squamous cell carcinoma, the
most common malignant tumor of the head and neck. Radio-
graphical evaluation of two cases MFH affecting maxillary
alveolar bone had been described by Sato et al.15 They rep-
resented in details the radiographical findings, which have
seldom been described in previous reports. They reported
the following findings, the presence of fairly well demar-
cated bone destruction in the intraoral radiograph, the rel-
atively smooth surface, uniform density, or no necrotic area
of the tumor. In computed tomography images, tumor
showed clear separation of the tumor from surrounding soft
tissues bone scintigraphs reflecting the periosteal reaction
to tumor invasion and lymphoscintigraphy of the metastatic
lymph nodes.15 Generally MFH of the maxilla dose not differ
from tumors arising in flat bones in other parts of the skel-
eton. In our case, CT scan revealed an ill defined soft tissue
mass with heterogeneous enhancement noted in the left
palatine region with central non-enhancement suggestive
of central necrosis. These findings are different from the
finding described previously.15
Most maxilla MFH exhibited a broad range of histological
patterns. Information regarding histological type was avail-
able in cases reviewed from literature. Storiform-pleomor-
phic was the prominent type in most cases. One case
revealed an anaplastic sarcomatous zone of the malignant
fibrous histiocytoma (MFH) type.23 However, only one case
Figure 6 Transmission electron microscopy photomicrographs, revealed storiform and pleomorphic MFH: (A) large fibroblastic
tumor cell with prominent periphery filaments with pleomorphic nucleus, (B) histiocyte revealed multi-segmented nucleus and
dilated RER, (C) giant cell tumor revealed significant accumulation of vimentin intermediate filaments and (D) histiocytes revealed
giant nucleus with RER containing a finely granular substance and a more electron dense material.
Figure 5 Photomicrographs of immunohistochemically, most of the tumor cells were strongly positive for vimentin: (A) low power
magnification (·200) and (B) high-power magnification (·400).
120 K.A. Al-Salihi et al.showed Pr/MFH/High grade.16 Our patient showed typical a
storiform pattern, contained interlacing a mix of pleomor-
phic fibroblasts and multi-nucleated cells arranged in
fascicles and myxoid pattern The cells revealed abnormal
high mitotic index. We suggested high grade of storiform
MFH. Nevertheless, the term MFH is widely used in routine
pathological practice for pleomorphic soft tissue sarcoma
without specific line of differentiation. MFH is included in
the category of fibrohistiocytic tumors. The presence of a
large number of histiocyte-like or histiocytic cells in the
pleomorphic sarcoma raised the question of biphasic
(fibroblastic–myofibroblastic and histiocytic) differen-
tiation.4,14The trend for some pathologists to diagnose malignant fi-
brous histiocytoma (MFH) less frequently than others may
result from different diagnostic criteria for MFH among
pathologists, reflecting the concept of MFH as a common
morphological manifestation of a variety of poorly differen-
tiated sarcomas, and the diagnosis of MFH through a process
of exclusion.45,46 It was concluded that a re-evaluation of
the diagnostic criteria was essential for so called MFH.
‘‘Ultrastructural observation of neoplastic cells suggests
that the expression of smooth muscle markers in so called
malignant fibrous histiocytoma is a result of myofibroblastic
differentiation’’. Smooth muscle markers, such as smooth
muscle actin (SMA) and occasionally even desmin, have
Maxilla tuberosity malignant fibrous histiocytoma with giant fibroblastic cells 121been demonstrated immunohistochemically in a subset of
‘‘MFH’’. In this situation, the distinction between leiomyo-
sarcoma and ‘‘MFH’’ becomes more difficult. Ultrastruc-
tural observation of neoplastic cells suggests that the
expression of smooth muscle markers in ‘‘MFH’’ is a result
of myofibroblastic differentiation.47–49 There are limited
data on the frequency and degree of positively for smooth
muscle markers in a large number of ‘‘MFHs’’.
A cases reported in literature demonstrated that most
cases were positive for vimentin and only few cases were po-
sitive for cytokeratin and desmin. In our case tumor was neg-
ative for epithelial markers, protein S-100 (a marker of
melanoma and schwann cell tumor) and desmin (smooth
muscle markers). But it was strong positive for vimentin
(mesenchymal markers). More recent histochemical, immu-
nohistochemical, and ultra structural studies of MFH support
the contention that MFH is a form of fibrosarcoma and the tu-
mor is very likely over diagnosed. This is because the more
pleomorphic the tumor the more difficult is to distinguish
from other types of sarcomas, such as pleomorphic leiomyo-
sarcoma, pleomorphic liposarcoma and dedifferentiated lip-
osarcoma. Distinction among these pleomorphic soft tissue
tumors is best achieved by a joint immunohistochemical
and ultrastructural study.2 Commonly, ultra structural find-
ings of MFH have demonstrated that tumor cells were com-
posed of fibroblast-like cells with abundant RER,
histiocyte-like cells with numerous lysosomes, and transi-
tional cells with characteristics of both the fibroblast-like
and histiocyte-like cell.50 Our present electron microscopic
observations compatible with typical ultra structural find-
ings reported previously. It revealed spindly or stellate fibro-
blast with long thin cytoplasmic processes as a cellular
collagen sparse and giant fibroblastic cells with markedly
pleomorphic multi-segmented nuclei and well developed
branching RER, primarily peripheral bundles of actin micro-
filaments with interspersed fusiform densities. In response
to inflammation and injury, the fibroblast often transforms
into contractile myfibroblast with peripheral arrays of actin
microfilaments and/or a fibrohistocytes with prominent lyso-
some that is often mistaken for a true histocytes. Although
the histocytes in MFH are though by some to be neoplastic,
the origin of both histocyte-like cells and multi-nucleated
giant cells in MFH has been the subject of much debate.51
Most of the cases 54/61 (88.5%) reported in literature re-
view were treated surgically. In 4/61 (6.5%) cases, surgery
was followed with post-operative radiotherapy and in other
4/61 (6. 5%) cases was followed with post-operative chemo-
therapy. While in 3/61 (4.9%) cases radiotherapy and che-
motherapy had been used. Only one case was treated with
chemotherapy and bounding, which resulted in a large
reduction tumor size without surgery.12 The proportion of
local recurrence rate of MFH after initial local excision
ranges between 16% and 52%.52,53 The presences of positive
surgical margins after definitive treatment is the single most
important factor relating to local recurrence.52 According
to Barnes and Kanbour,54 80% of patients with local recur-
rences after incomplete surgical treatment subsequently
die from disease. Recurrence is related to size, depth of
invasion, and microscopically positive surgical margins.
From the review of literature we found 9/61 (14.7%) recur-
rent cases and 3/61 (4.9%) non-recurrent cases while other
cases, they did not mentioned about the recurrence. In 6/61(9.8%) cases of maxilla MFH reported metastasized distantly
to lung, skin, local, bone, pleurae, pancreas, kidneys and
bone marrows.5,23,33,37 Only 6/61 (9.8%) cases survived with
out disease while all other case died with disease or lived
with deteriorates condition. In our case the patient came
4 months later with recurrence lesion confirmed histopatho-
logically.
In conclusion, we believe that MFH of the maxilla may
have poorer prognosis than those tumors in the other parts
of the maxillofacial skeleton. Size, depth, histopathologic
features, immunohistochemistry and ultrastructural fea-
tures, surgical margin status and adjuvant radiotherapy or
chemotherapy are the most important predictors of
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